NIGRO, Gerardo
 Distribuzione geografica
Continente #
EU - Europa 12.140
AS - Asia 4.450
NA - Nord America 4.245
SA - Sud America 869
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 21.774
Nazione #
RU - Federazione Russa 7.847
US - Stati Uniti d'America 4.173
SG - Singapore 1.727
IE - Irlanda 1.351
CN - Cina 1.027
HK - Hong Kong 861
BR - Brasile 743
FR - Francia 600
GB - Regno Unito 489
DE - Germania 465
IT - Italia 445
UA - Ucraina 390
KR - Corea 240
VN - Vietnam 212
SE - Svezia 182
IN - India 129
FI - Finlandia 122
GR - Grecia 116
AR - Argentina 59
TR - Turchia 59
JP - Giappone 54
AT - Austria 32
CA - Canada 29
ID - Indonesia 25
MX - Messico 24
BD - Bangladesh 22
ZA - Sudafrica 21
IQ - Iraq 20
BE - Belgio 19
EC - Ecuador 18
PL - Polonia 17
CZ - Repubblica Ceca 15
NL - Olanda 14
UZ - Uzbekistan 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
CO - Colombia 9
ES - Italia 9
MA - Marocco 9
PK - Pakistan 9
PY - Paraguay 9
SA - Arabia Saudita 8
VE - Venezuela 8
AL - Albania 6
KE - Kenya 6
EU - Europa 5
UY - Uruguay 5
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
JM - Giamaica 4
LB - Libano 4
NI - Nicaragua 4
PE - Perù 4
AU - Australia 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
QA - Qatar 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
Totale 21.774
Città #
Moscow 2.753
Dublin 1.351
Santa Clara 894
Hong Kong 855
Jacksonville 653
Singapore 619
Chandler 518
Seoul 239
Princeton 191
Hefei 190
Medford 155
Bremen 147
Roxbury 145
Beijing 112
Bengaluru 98
Dallas 91
Ann Arbor 86
Ashburn 86
Ho Chi Minh City 83
The Dalles 83
Wilmington 81
Boardman 76
San Mateo 63
São Paulo 63
Caserta 56
Hanoi 49
Cambridge 45
Des Moines 44
Nuremberg 44
Woodbridge 44
Munich 43
Naples 38
New York 37
Falkenstein 33
Belo Horizonte 32
Guangzhou 26
Jinan 25
Nanjing 23
Aversa 22
Düsseldorf 20
Los Angeles 20
Nanchang 20
Milan 18
Rio de Janeiro 18
Tianjin 18
Brussels 17
Mountain View 17
Houston 16
Helsinki 15
Norwalk 15
Hangzhou 14
Shenyang 14
Brno 13
Changsha 13
Rome 13
Zhengzhou 13
Hebei 12
Redwood City 12
Brasília 11
Lanzhou 11
Turku 11
Vienna 11
Warsaw 11
Brooklyn 10
Da Nang 10
Guarulhos 10
London 10
Marano Di Napoli 10
Napoli 10
Porto Alegre 10
Salvador 10
Taizhou 10
Columbus 9
Ercolano 9
Lappeenranta 9
Shanghai 9
Taiyuan 9
Tashkent 9
Tokyo 9
Toronto 9
Guayaquil 8
Haikou 8
Atlanta 7
Baghdad 7
Cape Town 7
Chicago 7
Curitiba 7
Frankfurt am Main 7
Johannesburg 7
Manaus 7
Paris 7
Amsterdam 6
Auburn Hills 6
Campinas 6
Dhaka 6
Haiphong 6
Jakarta 6
Manchester 6
Natal 6
Quito 6
Totale 10.841
Nome #
A longitudinal study on BIO14.6 hamsters with dilated cardiomyopathy: Micro-echocardiographic evaluation 160
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 156
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 155
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 154
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 146
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 143
Anaesthesia and Rare Neuromuscular Diseases 142
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 141
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 140
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 138
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 138
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 137
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 137
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 136
Novel mutations in LMNA A/C gene and associated phenotypes 136
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 136
Cardiomyopathies associated with Muscular Dystrophies 134
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 132
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 130
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 130
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 130
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 130
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 130
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 130
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 129
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 128
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 127
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 127
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 126
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 126
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 124
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 124
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 124
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 124
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 124
Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene 124
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 123
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 123
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti ai campi elettromagnetici ELF 123
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 122
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 122
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 121
Arrhythmic risk in Steinert Disease 121
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. 120
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 119
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 118
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 118
Advances in basic and clinical research in laminopathies. 118
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 117
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 116
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 115
P3.14 New AAVs for the muscle gene therapy in sarcoglycan deficient animals 115
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 114
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 114
The QT dispersion in the risk stratification of sudden death in Becker patients 114
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments 113
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 113
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 112
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 111
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 110
ST-segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis? 110
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 109
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 109
Heart involvement in Emery-Dreifuss muscular dystrophies: new parameters to detect early atrial fibrosis and vulnerability 108
Idiopathic left ventricular tachycardia: Evidence of a his bundle 'bystander' participation 106
Ablate and pace: Comparison of outcomes between conduction system pacing and biventricular pacing 105
Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise 105
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 105
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 104
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 103
Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients 103
Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation 101
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 101
Ischemic heart disease therapy in the elderly: Risk/benefit ratio 100
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 100
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results 100
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 100
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 99
Atrioventricular Interval Extension Is Highly Efficient in Preventing Unnecessary Right Ventricular Pacing in Sinus Node Disease: A Randomized Cross-Over Study Versus Dual- to Atrial Single-Chamber Mode Switch 99
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 98
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 97
Evaluation of Becker cardiomyopathy by Vest investigation 97
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 97
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 97
Risk of arrhythmia in type I Myotonic Dystrophy: the role of clinical and genetic variables 96
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 96
Rischio aritmico nella Distrofia Miotonica tipo 1 (Studio RAMYD): Risultati preliminari ad un anno 96
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 96
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 95
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response 94
Heart rate variability, obesity, and bariatric-induced weight loss: the importance of selection criteria 94
Interazione tra campi elettromagnetici ELF e ritmo cardiaco in macchinisti di veicoli a trazione elettrica: ricerca di un indice predittivo di rischio aritmico 94
X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers. 94
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 94
A simplified cardiac implantable electronic device infection classification by combining key diagnostic criteria 93
Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report. 93
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti a campi elettromagnetici ELF. Atti del 64° Congresso Nazionale SIMLII 93
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 93
Prevalence and clinical predictors of vasodepressor syncope during head up tilt test 92
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients 92
Totale 11.618
Categoria #
all - tutte 76.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021593 0 0 0 0 0 11 147 101 15 121 159 39
2021/20221.329 68 26 52 48 400 4 10 36 43 191 96 355
2022/20232.296 222 43 23 175 263 160 7 111 1.204 21 37 30
2023/2024848 55 39 38 65 343 32 15 21 4 17 60 159
2024/20253.466 19 27 15 73 503 560 340 279 452 699 270 229
2025/202611.221 532 671 743 771 1.044 7.460 0 0 0 0 0 0
Totale 22.233